Soolantra has not been studied in patients with renal or hepatic impairment.
The medicinal product contains: cetyl alcohol and stearyl alcohol which may cause local skin reactions (e.g. contact dermatitis); methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) which may cause allergic reactions (possibly delayed); and propylene glycol which may cause skin irritation.
Effects on ability to drive and use machines: Soolantra has no or negligible influence on the ability to drive and use machines.